As immunity plays a pivotal role in the natural course of HBV, the outcome of the infection, and the pathogenesis of liver disease, the genes encoding inflammatory mediators (e.g., TNF-α, TGF-β, and IL-37) may be prospective candidates to predict the progression of HBV-mediated disease severity36,37. The gene discussed is TGFB1; the disease is liver disorder.